If applicable, patient with >= grade 2 peripheral neuropathy within 14 days before enrollment
Grade 3 peripheral neuropathy within 14 days before enrollment.
> Grade 1 peripheral neuropathy within 14 days before enrollment.
Patient with peripheral neuropathy Grade >2
Patient has >= grade 2 peripheral neuropathy within 14 days of trial enrollment
Patient has >= grade 2 peripheral neuropathy within 14 days before enrollment and at D60-180 after AHCT; patients who had >= grade 2 peripheral neuropathy within 14 days before enrollment but resolves to grade 1 or lower peripheral neuropathy at D60-D180 after AHCT can be enrolled at this time
Patient has >= grade 2 peripheral neuropathy
Patient has >= grade 2 peripheral neuropathy
The patient has peripheral neuropathy >= grade 2
Patient has >= grade 2 peripheral neuropathy within 14 days before enrollment
Patient has >= grade 2 peripheral neuropathy within 14 days before enrollment
Grade >= 2 peripheral neuropathy within 21 days before enrollment
Patient must not have >= grade 2 peripheral neuropathy within 14 days before enrollment
Patient has >= grade 2 peripheral neuropathy
Patient has >= grade 2 (CTCAE v 4.0) peripheral neuropathy within 14 days before enrollment
Patient has >= grade 2 peripheral neuropathy within 14 days before enrollment
Patient has > = Grade 2 peripheral neuropathy within 14 days before enrollment.
Subject has > grade 2 peripheral neuropathy within 14 days before enrollment
Grade >= 2 peripheral neuropathy within 14 days before enrollment
Patient has >/= Grade 2 peripheral neuropathy within 14 days before enrollment.
No grade 2 >= peripheral neuropathy within 14 days before enrollment
Patient has >= grade 2 peripheral neuropathy
If applicable, patient has >= Grade 2 peripheral neuropathy within 14 days before enrollment
Patient has >= grade 2 peripheral neuropathy
If applicable, patient has >= grade 2 peripheral neuropathy within 14 days before enrollment
Patient has >= grade 2 peripheral neuropathy within 14 days prior to treatment initiation
